000			01997 a2200673 4500
005			20250516022113.0
264		0	_c20111216
008			201112s 0 0 eng d
022			_a1096-9071
024	7		_a10.1002/jmv.21976 _2doi
040			_aNLM _beng _cNLM
100	1		_aNicot, F
245	0	0	_aInfluence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy. _h[electronic resource]
260			_bJournal of medical virology _cMar 2011
300			_a437-44 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntiviral Agents _xblood
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGenotype
650	0	4	_aHIV Infections _xcomplications
650	0	4	_aHepacivirus _xdrug effects
650	0	4	_aHepatitis C, Chronic _xdrug therapy
650	0	4	_aHumans
650	0	4	_aInterferon-alpha _xblood
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPolyethylene Glycols _xtherapeutic use
650	0	4	_aProspective Studies
650	0	4	_aRecombinant Proteins _xblood
650	0	4	_aRibavirin _xblood
650	0	4	_aTreatment Outcome
650	0	4	_aViral Load
700	1		_aAlric, L
700	1		_aBarange, K
700	1		_aMétivier, S
700	1		_aDramard, J M
700	1		_aCombis, J M
700	1		_aCastan, B
700	1		_aMeurisse, J J
700	1		_aPayen, J L
700	1		_aGaripuy, D
700	1		_aDesmorat, H
700	1		_aPeron, J M
700	1		_aThebault, S
700	1		_aMorin, T
700	1		_aRenou, C
700	1		_aBarel, P
700	1		_aGuerin, B
700	1		_aImbert, Y
700	1		_aSire, S
700	1		_aSauné, K
700	1		_aChatelut, E
700	1		_aIzopet, J
773	0		_tJournal of medical virology _gvol. 83 _gno. 3 _gp. 437-44
856	4	0	_uhttps://doi.org/10.1002/jmv.21976 _zAvailable from publisher's website
999			_c20545597 _d20545597